Medical Condition News

RSS

Insights into type I diabetes

A new signal pathway that renders the insulin-releasing beta cell more sensitive to high levels of blood glucose has been discovered by researchers at the Swedish medical university Karolinska Institutet. A second new study reveals a possible way to delay the disease by inhibiting a lipoprotein.

23 Jun 2011

FDA reveals graphic new cigarette warning labels

"Nearly a half-century after U.S. cigarette packs were emblazoned with their first, modest warning, 'Caution: Cigarette Smoking May be Hazardous to Your Health,' the Food and Drug Administration - at Congress' behest - is … requiring tobacco companies to print painful images, such as that of a man smoking through a hole in his throat or of a lip eroded by cancer and a mouthful of rotting teeth, right on their cigarette packs," the Philadelphia Inquirer reports.

23 Jun 2011

SNP identification may help predict patients’ susceptibility to postoperative nausea and vomiting

There are several anesthetic complications that may have a hereditary background, including postoperative nausea and vomiting (PONV). Past observations have shown PONV to occur in blood relatives as far back as two to three generations.

23 Jun 2011

New sAPPβ biomarker may identify people at risk of developing Alzheimer's

A new biomarker may help identify which people with mild memory deficits will go on to develop Alzheimer's disease, according to a new study published in the June 22, 2011, online issue of Neurology, the medical journal of the American Academy of Neurology.

23 Jun 2011

Study reveals 29% decline in bicycle-related head injuries after mandatory helmet laws

Bicycle-related head injuries fell significantly in the months after mandatory helmet legislation came into effect in NSW, and recent calls for a repeal of the laws should be rejected, new research based on hospital admissions data shows.

23 Jun 2011

St. Jude Medical announces results of Genesis neurostimulator trial on chronic migraine

St. Jude Medical, Inc., a global medical device company, today announced study results on the safety and efficacy of peripheral nerve stimulation (PNS) of the occipital nerve for the management of pain and disability associated with chronic migraine, a debilitating condition that affects millions worldwide.

23 Jun 2011

MEDA seeks marketing authorization for Zyclara in Europe

“Zyclara will strengthen Meda's dermatology franchise in Europe. We look forward to provide AK patients with a new product that can treat larger areas of the skin”

23 Jun 2011

Diamyd Medical to terminate US DiaPrevent Phase III study for type 1 diabetes

Diamyd Medical AB reports that the Company has decided to suspend dosing in a US Phase III study with the antigen-based therapy Diamyd and to initiate closure of the study.

23 Jun 2011

Unraveling molecular dysfunction due to environmental toxin exposure

In a new article published in the journal Molecular Neurodegeneration, researchers at the University of Missouri School of Medicine take some of the first steps toward unraveling the molecular dysfunction that occurs when proteins are exposed to environmental toxins. Their discovery helps further explain recent NIH findings that demonstrate the link between Parkinson's disease and two particular pesticides - rotenone and paraquat.

23 Jun 2011

ULMCA PCI with DES a viable option for low-risk patients with normal left ventricular function

Patients with normal left ventricular function who undergo elective unprotected left main coronary artery (ULMCA) percutaneous coronary intervention (PCI) with drug-eluting stents (DES) had favorable outcomes according to new research.

23 Jun 2011

New surprising details about flow of neurotransmitters between brain neurons

Two studies featuring research from Weill Cornell Medical College have uncovered surprising details about the complex process that leads to the flow of neurotransmitters between brain neurons -- a dance of chemical messages so delicate that missteps often lead to neurological dysfunction.

23 Jun 2011

Axxam receives ADDF grant to develop new therapeutics for Alzheimer's

The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it has awarded a grant to Axxam SpA to develop small molecules to treat Alzheimer's disease by targeting inflammation.

23 Jun 2011

Surgical lung injury prediction model can help identify patients at high risk of ALI

A new study in the July issue of Anesthesiology helped developed a model that could determine which patients are at high risk of developing acute lung injury.

23 Jun 2011

CPDC, UHN to advance use of medical isotopes for cancer treatment and diagnosis

CanProbe, a unique, not-for-profit joint venture to advance the use of medical isotopes for diagnosing and treating cancer and other serious diseases, was announced today by the Centre for Probe Development and Commercialization (CPDC) and the University Health Network.

23 Jun 2011

AstraZeneca, Jubilant announce delivery outcomes and early success in Pain therapeutic area

Biosys Ltd., Bengaluru, based subsidiary of Jubilant Life Sciences Ltd., and AstraZeneca, today announced another successful delivery of an early stage milestone in the Pain therapeutic area.

23 Jun 2011

Autistic toddlers’ brain research may help early diagnosis: Study

Researchers have noted that the brain activities of toddlers with autism appears to be out of sync at a very early stage -- a finding that sheds light on the biology of the condition and might help in earlier diagnosis. The study was published in the journal Neuron.

23 Jun 2011

Urban dwellers at greater risk of mental illness: Study

A new study shows that living in a city increases the risk of developing a mental disorder, including depression and schizophrenia, compared to people who live in non-urban areas. The findings of the has implications for around half of the world's population who live in cities.

23 Jun 2011